These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21288305)

  • 21. Small molecular CD4 mimics as HIV entry inhibitors.
    Narumi T; Arai H; Yoshimura K; Harada S; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2011 Nov; 19(22):6735-42. PubMed ID: 22014753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action.
    Langley DR; Kimura SR; Sivaprakasam P; Zhou N; Dicker I; McAuliffe B; Wang T; Kadow JF; Meanwell NA; Krystal M
    Proteins; 2015 Feb; 83(2):331-50. PubMed ID: 25401969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.
    Zaitseva M; Peden K; Golding H
    Biochim Biophys Acta; 2003 Jul; 1614(1):51-61. PubMed ID: 12873765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PHOENIX: a scoring function for affinity prediction derived using high-resolution crystal structures and calorimetry measurements.
    Tang YT; Marshall GR
    J Chem Inf Model; 2011 Feb; 51(2):214-28. PubMed ID: 21214225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding.
    Wu H; Myszka DG; Tendian SW; Brouillette CG; Sweet RW; Chaiken IM; Hendrickson WA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15030-5. PubMed ID: 8986758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
    Wang H; Cohen AA; Galimidi RP; Gristick HB; Jensen GJ; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7151-E7158. PubMed ID: 27799557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein.
    Brand D; Srinivasan K; Sodroski J
    J Virol; 1995 Jan; 69(1):166-71. PubMed ID: 7983707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
    Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
    J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.
    Andrianov AM; Nikolaev GI; Kornoushenko YV; Xu W; Jiang S; Tuzikov AV
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31412617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 protease inhibitors: enthalpic versus entropic optimization of the binding affinity.
    Velazquez-Campoy A; Todd MJ; Freire E
    Biochemistry; 2000 Mar; 39(9):2201-7. PubMed ID: 10694385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
    Thali M; Olshevsky U; Furman C; Gabuzda D; Li J; Sodroski J
    J Virol; 1991 Sep; 65(9):5007-12. PubMed ID: 1870209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.
    Finzi A; Xiang SH; Pacheco B; Wang L; Haight J; Kassa A; Danek B; Pancera M; Kwong PD; Sodroski J
    Mol Cell; 2010 Mar; 37(5):656-67. PubMed ID: 20227370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding.
    Wang HG; Williams RE; Lin PF
    Curr Pharm Des; 2004; 10(15):1785-93. PubMed ID: 15180540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rationally designed synthetic mimic of the discontinuous CD4-binding site of HIV-1 gp120.
    Franke R; Hirsch T; Eichler J
    J Recept Signal Transduct Res; 2006; 26(5-6):453-60. PubMed ID: 17118792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of CD4/gp120 inhibitors by thermodynamic-guided alanine-scanning mutagenesis.
    Liu Y; Schön A; Freire E
    Chem Biol Drug Des; 2013 Jan; 81(1):72-8. PubMed ID: 23066870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.